JP2008544949A - 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 - Google Patents

化膿性レンサ球菌のための免疫激性組成物および治療用組成物 Download PDF

Info

Publication number
JP2008544949A
JP2008544949A JP2007535816A JP2007535816A JP2008544949A JP 2008544949 A JP2008544949 A JP 2008544949A JP 2007535816 A JP2007535816 A JP 2007535816A JP 2007535816 A JP2007535816 A JP 2007535816A JP 2008544949 A JP2008544949 A JP 2008544949A
Authority
JP
Japan
Prior art keywords
gas
seq
protein
antigen
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007535816A
Other languages
English (en)
Japanese (ja)
Inventor
ジュリアーノ ベンシー，
グイド グランディ，
ナタリー ノーレイズ，
マニュエル ロドリゲス ジェイ． オルテガ，
Original Assignee
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド filed Critical ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Publication of JP2008544949A publication Critical patent/JP2008544949A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2007535816A 2004-10-08 2005-10-11 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 Withdrawn JP2008544949A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61685404P 2004-10-08 2004-10-08
US65273605P 2005-02-15 2005-02-15
US70112105P 2005-07-21 2005-07-21
US70520905P 2005-08-04 2005-08-04
PCT/US2005/036009 WO2006042027A2 (en) 2004-10-08 2005-10-11 Immunogenic and therapeutic compositions for streptococcus pyogenes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012071927A Division JP2012126742A (ja) 2004-10-08 2012-03-27 化膿性レンサ球菌のための免疫激性組成物および治療用組成物

Publications (1)

Publication Number Publication Date
JP2008544949A true JP2008544949A (ja) 2008-12-11

Family

ID=35720938

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007535816A Withdrawn JP2008544949A (ja) 2004-10-08 2005-10-11 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
JP2012071927A Pending JP2012126742A (ja) 2004-10-08 2012-03-27 化膿性レンサ球菌のための免疫激性組成物および治療用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012071927A Pending JP2012126742A (ja) 2004-10-08 2012-03-27 化膿性レンサ球菌のための免疫激性組成物および治療用組成物

Country Status (6)

Country Link
US (1) US7838010B2 (cg-RX-API-DMAC7.html)
EP (1) EP1807446A2 (cg-RX-API-DMAC7.html)
JP (2) JP2008544949A (cg-RX-API-DMAC7.html)
AU (1) AU2005294275B2 (cg-RX-API-DMAC7.html)
CA (1) CA2583803C (cg-RX-API-DMAC7.html)
WO (1) WO2006042027A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014508783A (ja) * 2011-03-18 2014-04-10 エドゥアルド ナウウィル，アレクサンドル 免疫系を調節するための免疫原性組成物およびその使用、疾患を治療および予防する方法、細胞再生を誘発する方法、ならびに免疫応答を更新する方法

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
RU2352356C2 (ru) * 2003-06-26 2009-04-20 Новартис Вэксинес Энд Дайэгностикс, Инк. ИММУНОГЕННАЯ КОМПОЗИЦИЯ НА ОСНОВЕ АНТИГЕНА Chlamydia trachomatis (ВАРИАНТЫ) И ЕЕ ИСПОЛЬЗОВАНИЕ
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1807446A2 (en) 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
EP2287189A1 (en) * 2006-07-07 2011-02-23 Intercell AG Small Streptococcus pyogenes antigens and their use
JP2010508276A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 化膿連鎖球菌のための免疫原性組成物および治療組成物
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
EP2173902A4 (en) * 2007-07-03 2013-01-09 Mt Sinai Hospital THERAPEUTICS AND DIAGNOSTICS FOR GROUP A STREPTOKOKKEN
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
GB0721757D0 (en) * 2007-11-06 2007-12-19 Novartis Ag Streptococcus pyogenes classification
WO2009155484A2 (en) 2008-06-20 2009-12-23 Wyeth Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
SI2344523T1 (sl) * 2008-09-17 2016-06-30 Glaxosmithkline Biologicals S.A. Kombinirana GAS-cepiva in zdravila
RU2478396C2 (ru) * 2008-11-05 2013-04-10 ВАЙЕТ ЭлЭлСи МНОГОКОМПОНЕНТНАЯ ИММУНОГЕННАЯ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЯ, ВЫЗВАННОГО β-ГЕМОЛИТИЧЕСКИМИ СТРЕПТОКОККАМИ (БГС)
EP2385842A1 (en) 2009-01-12 2011-11-16 Novartis AG Cna_b domain antigens in vaccines against gram positive bacteria
GB0903858D0 (en) * 2009-03-05 2009-04-22 Novartis Ag Diagnosis of disease
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
GB201002362D0 (en) 2010-02-11 2010-03-31 Isis Innovation Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
US8697085B2 (en) * 2011-06-17 2014-04-15 University Of Tennessee Research Foundation Group A Streptococcus multivalent vaccine
CA2945052C (en) 2014-04-15 2023-05-02 Griffith University Group a streptococcus vaccine
WO2015169773A2 (en) * 2014-05-07 2015-11-12 Glaxosmithkline Biologicals S.A. Mutants of spy0269
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
TWI598360B (zh) * 2016-12-19 2017-09-11 義守大學 Ｆｓｂｍ重組蛋白及其用途
KR20190139289A (ko) * 2017-04-26 2019-12-17 오클랜드 유니서비시즈 리미티드 분석 및 치료 방법과 조성물, 그리고 이의 용도
CN108379572A (zh) * 2018-01-25 2018-08-10 暨南大学 一种化脓链球菌HtsA蛋白质疫苗以及制备方法和应用
CN110922456B (zh) * 2019-12-28 2023-02-24 重庆艾力彼生物科技有限公司 铜绿假单胞菌疫苗重组蛋白reSBP-ExoU及制备方法和应用
WO2022256310A1 (en) * 2021-06-01 2022-12-08 The Regents Of The University Of California Protective vaccine antigen against streptococcal infection
GB202215414D0 (en) 2022-10-18 2022-11-30 Glaxosmithkline Biologicals Sa Vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078907A2 (en) * 2003-03-04 2004-09-16 Intercell Ag Streptococcus pyogenes antigens
WO2005032582A2 (en) * 2003-07-31 2005-04-14 Chiron Corporation Immunogenic compositions for streptococcus pyogenes

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US4454121A (en) 1982-07-27 1984-06-12 The University Of Tennessee Research Corporation Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
US5098827A (en) 1988-02-26 1992-03-24 The University Of Florida Novel bacterial markers for pathogenic group B streptococci
US5354846A (en) 1988-11-18 1994-10-11 Michael Kehoe Streptolysin O antigen derivatives, its production and uses
GB8827038D0 (en) 1988-11-18 1988-12-21 Kehoe M Streptolysin o antigens & uses
DE68929323T2 (de) 1988-12-16 2002-04-18 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Pneumolysin-mutanten und pneumokokken-impfstoffe daraus
GB2233977B (en) 1989-01-04 1993-03-31 Michael Kehoe Cytolytic streptolysin o mutants and uses
US6737521B1 (en) 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US5821088A (en) 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
US5378620A (en) 1991-08-30 1995-01-03 Beckman Instruments, Inc. Streptolysin O derivatives
US5391712A (en) 1991-08-30 1995-02-21 Beckman Instruments, Inc. Non-hemolytic streptolysin O variants
DE4240056A1 (de) 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
PT613947E (pt) 1993-02-01 2004-07-30 Beckman Coulter Inc Factor mitogenico seu gene e metodo para a sua microdeteccao
DE69433107T2 (de) 1993-06-23 2004-07-08 Beckman Coulter, Inc., Fullerton Rekombinante dnase b aus streptococcus pyogenes
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
PT804559E (pt) 1994-10-07 2005-08-31 Univ Rockefeller Enzima para clivagem da regiao ancora de proteinas de superficie de bacterias gram-positivas
AUPM885194A0 (en) 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
US5799981A (en) * 1995-05-12 1998-09-01 Global Healthcomm, Inc. Pharmaceutical marketing device and system
US6067088A (en) * 1995-05-18 2000-05-23 Canon Kabushiki Kaisha Image processing method and apparatus thereof
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6936259B2 (en) 1995-06-08 2005-08-30 University Of Saskatchewan CAMP factor of Streptococcus uberis
US5819228A (en) * 1995-10-31 1998-10-06 Utilimed, Inc. Health care payment system utilizing an intensity adjustment factor applied to provider episodes of care
US6014634A (en) * 1995-12-26 2000-01-11 Supermarkets Online, Inc. System and method for providing shopping aids and incentives to customers through a computer network
US5846547A (en) 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6346392B1 (en) 1996-11-27 2002-02-12 Smithkline Beecham Corporation Polynucleotides encoding a novel glutamine transport ATP-binding protein
US6272481B1 (en) * 1996-05-31 2001-08-07 Lucent Technologies Inc. Hospital-based integrated medical computer system for processing medical and patient information using specialized functional modules
IES76925B2 (en) 1996-07-03 1997-11-19 Provost Subunit Vaccine for Streptococcus Equi
EP0821070A1 (en) 1996-07-22 1998-01-28 Carelli, Claude Marcel Henri Pit-1 gene polymorphism and trait selection in animals
DE69739981D1 (de) 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
WO1998019689A1 (en) 1996-11-01 1998-05-14 Smithkline Beecham Corporation Novel coding sequences
US7033765B1 (en) 1997-02-20 2006-04-25 Toronto Research Chemicals, Inc. Site-specific drug delivery
US6426074B1 (en) 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US6256614B1 (en) * 1997-04-17 2001-07-03 Jeff H. Wecker Internet system for producing electronic reward cards
KR20010012236A (ko) 1997-05-06 2001-02-15 벤슨 로버트 에이치. 엔테로코쿠스 파에칼리스 폴리뉴클레오티드 및 폴리펩티드
US6635623B1 (en) 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
EP1003875B1 (en) 1997-09-12 2006-12-27 University of Tennessee Research Foundation Group a streptococcal vaccines
EP1037997A1 (en) 1997-09-26 2000-09-27 Medimmune, Inc. Lmb gene of streptococcus agalactiae
US6406883B1 (en) 1997-09-26 2002-06-18 Luetticken Rudolf Lmb gene of Streptococcus agalactiae
US6035276A (en) * 1997-10-17 2000-03-07 Veritas Medical Services, Inc. Medical practitioner credentialing system
BR9813071A (pt) 1997-10-17 2000-08-15 Nestle Sa Espécie de bactéria láctica
WO1999026969A1 (en) 1997-11-21 1999-06-03 University Of Otago Zoocin a immunity factor
WO1999035270A1 (en) 1997-12-31 1999-07-15 Stressgen Biotechnologies Corporation Streptococcal heat shock proteins of the hsp60 family
US7041814B1 (en) 1998-02-18 2006-05-09 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics
ID27482A (id) 1998-02-20 2001-04-12 Iaf Biochem Int Antigen streptococcus kelompok b
GB9808327D0 (en) 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
US6660520B2 (en) 1998-06-05 2003-12-09 Smithkline Beecham Corporation Nrde
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6076525A (en) * 1999-01-28 2000-06-20 Hoffman; Michael D. Frame for prone surgical positioning
US7101692B2 (en) 1999-04-15 2006-09-05 The Regents Of The University Of California Identification of sortase gene
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
EP1265582A2 (en) 1999-09-29 2002-12-18 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
US6777547B1 (en) 2000-01-31 2004-08-17 Andreas Podbielski Collagen-binding proteins from streptococcus pyogenes
WO2001070955A2 (en) 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
AUPQ801700A0 (en) 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
JP4718099B2 (ja) 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
DE60128115T2 (de) 2000-08-08 2008-03-06 St. Jude Children's Research Hospital, Memphis Gruppe-b streptococcus polypeptide, nukleinsäure, therapeutische zusammensetzungen und impfstoffe davon
WO2002057315A2 (en) 2000-10-10 2002-07-25 University Of Tennessee Research Corporation Streptococcal streptolysin s vaccines
US7160547B2 (en) 2000-10-10 2007-01-09 University Of Tennessee Research Corporation Streptococcal streptolysin S vaccines
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP1421098A4 (en) 2001-04-13 2006-03-15 Wyeth Corp SURFACE PROTEINS OF STREPTOCOCCUS PYOGENES
US20070128229A1 (en) 2002-04-12 2007-06-07 Wyeth Surface proteins of Streptococcus pyogenes
EP1399181B1 (en) 2001-05-18 2012-05-09 The Government of the USA, as represented by the Secretary, Dept. of Health and Human Services, Centers for Disease Control and Prevention Peptide vaccines against group a streptococci
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US20060073530A1 (en) 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
US20040029129A1 (en) 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
GB2385274B (en) 2002-02-13 2004-04-14 Ming-Jeng Shue Vaginal suppository delivery device
US20050181388A1 (en) 2002-04-02 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
WO2003087353A2 (en) 2002-04-08 2003-10-23 Affinium Pharmaceuticals, Inc. Purified polypeptides involved in membrane biogenesis
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
AU2003260102A1 (en) 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
ES2504166T3 (es) 2002-09-13 2014-10-08 Novartis Vaccines And Diagnostics, Inc. Vacuna de estreptococo del grupo B
TW566366U (en) 2002-09-27 2003-12-11 Wus Tech Co Ltd Labor-saving portable battery equipment for power-driven walking assisted scooter
CN1705679B (zh) 2002-10-15 2011-04-06 英特塞尔股份公司 编码b族链球菌粘着因子的核酸、b族链球菌的粘着因子和它们的用途
AU2004235952A1 (en) 2003-05-07 2004-11-18 Intercell Ag Streptococcus agalactiae antigens I + II
AU2003904237A0 (en) 2003-08-08 2003-08-21 Garvan Institute Of Medical Research Novel translocation assay
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2005076010A2 (en) 2004-02-06 2005-08-18 Council Of Scientific And Industrial Research Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
US20060041961A1 (en) 2004-03-25 2006-02-23 Abad Mark S Genes and uses for pant improvement
WO2005108419A1 (en) 2004-05-07 2005-11-17 Lea-Ann Kirkham Mutant cholesterol-binding cytolysin proteins
US20090317420A1 (en) 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
AU2005335216A1 (en) 2004-10-05 2007-02-15 Wyeth Probe arrays for detecting multiple strains of different species
EP1807446A2 (en) 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2006069200A2 (en) 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics Inc. Group b streptococcus
EP1770171A1 (en) 2005-09-29 2007-04-04 Universität Zu Köln DNA microarray for rapid identification of Candida albicans in blood cultures.
EP2287189A1 (en) 2006-07-07 2011-02-23 Intercell AG Small Streptococcus pyogenes antigens and their use
CN104292312A (zh) 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078907A2 (en) * 2003-03-04 2004-09-16 Intercell Ag Streptococcus pyogenes antigens
WO2005032582A2 (en) * 2003-07-31 2005-04-14 Chiron Corporation Immunogenic compositions for streptococcus pyogenes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN5007017414; ＮＡＫＡＧＡＷＡ　ＩＣＨＩＲＯ: ＧＥＮＯＭＥ　ＲＥＳＥＡＲＣＨ Ｖ１３　Ｎ６Ａ, 200306, Ｐ１０４２-１０５５ *
JPN5007017415; ＳＭＯＯＴ　Ｊ　Ｃ: ＰＲＯＣＥＥＤＩＮＧＳ　ＯＦ　ＴＨＥ　ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥＳ　ＯＦ　ＵＳＡ Ｖ９９　Ｎ７, 20020402, Ｐ４６６８-４６７３, ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥ *
JPN5007017416; ＢＡＮＫＳ　Ｄ　Ｊ: ＪＯＵＲＮＡＬ　ＯＦ　ＩＮＦＥＣＴＩＯＵＳ　ＤＩＳＥＡＳＥＳ Ｖ１９０　Ｎ４, 20040815, Ｐ７２７-７３８ *
JPN5007017417; ＦＥＲＲＥＴＴＩ　Ｊ　Ｊ: ＰＲＯＣＥＥＤＩＮＧＳ　ＯＦ　ＴＨＥ　ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥＳ　ＯＦ　ＵＳＡ Ｖ９８　Ｎ８, 20010410, Ｐ４６５８-４６６３, ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥ *
JPN5007017418; ＯＬＩＶＥ　Ｃ: ＶＡＣＣＩＮＥ Ｖ２０　Ｎ２１-２２, 20020621, Ｐ２８１６-２８２５, ＢＵＴＴＥＲＷＯＲＴＨ　ＳＣＩＥＮＴＩＦＩＣ． *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014508783A (ja) * 2011-03-18 2014-04-10 エドゥアルド ナウウィル，アレクサンドル 免疫系を調節するための免疫原性組成物およびその使用、疾患を治療および予防する方法、細胞再生を誘発する方法、ならびに免疫応答を更新する方法

Also Published As

Publication number Publication date
WO2006042027A8 (en) 2006-11-02
AU2005294275A1 (en) 2006-04-20
US20090117113A1 (en) 2009-05-07
WO2006042027A3 (en) 2006-08-24
CA2583803C (en) 2014-11-25
CA2583803A1 (en) 2006-04-20
AU2005294275B2 (en) 2012-09-13
EP1807446A2 (en) 2007-07-18
WO2006042027A2 (en) 2006-04-20
JP2012126742A (ja) 2012-07-05
US7838010B2 (en) 2010-11-23

Similar Documents

Publication Publication Date Title
JP2012126742A (ja) 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
JP5680536B2 (ja) 組み合わせｇａｓワクチンおよび治療法
JP5656642B2 (ja) ストレプトリシンｏの変異体形態
US8377446B2 (en) Serum resistance factors of gram positive bacteria
JP2010508276A (ja) 化膿連鎖球菌のための免疫原性組成物および治療組成物
JP2014230547A (ja) Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
JP2010538634A5 (cg-RX-API-DMAC7.html)
AU2013203063A1 (en) Combination gas vaccines and therapeutics

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110927

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121107

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20130207